We are Epilepsy Society. The UK's leading charity for epilepsy research and support.
Due to current circumstances in relation to the coronavirus some of our services have been reduced with our staff working from home. Despite this our top priority at Epilepsy Society is to support people living with epilepsy. You may notice a slight change in our communications. For the time being, we will focus our efforts on making sure you have all the information you need from us to help you as best we can in the current climate.
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online harm, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy – putting your needs at the heart of what we do.
The Covid-19 booster vaccine is now available on the NHS for those who are most at risk from the virus and have had two doses of the vaccination at least six months ago. This includes people with epilepsy.
Following the tragic death of Sir David Amess MP, our Chief Executive, Clare Pelham, issued the following statement.
Would you like to find out more about climate change and the impact that it might have on epilepsy? Free virtual conference 25 Nov 2021.
One of the Epilepsy Society's three core pillars, alongside research and care, is advocacy – campaigning in support of the issues that matter most to people with epilepsy. This summer and early autumn, we have continued to campaign on a number of key issues.
We have had a lot of calls to our helpline from people with epilepsy who meet the DVLA standards and may be able to drive, but are waiting for their application to the DVLA to be processed.
Ten-year-old epilepsy campaigner, Zach Eagling, was honoured at a prestigious charity awards ceremony in central London in September 2021.
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
Our Helpline is open five days a week, Monday to Friday 9am to 4pm, (Wednesday 9am to 7.30pm).
You can also reach us by email